HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Are Beauty Ads Held To Unique Standards? NARB Ruling Spurs Debate

This article was originally published in The Rose Sheet

Executive Summary

At the National Advertising Division’s Annual Conference, NAD staffers, FTC officials and attorneys discussed whether beauty ads are regulated differently from advertising in other industries. L’Oreal’s successful appeal of a recent NAD decision regarding the use of lash inserts in Maybelline mascara ads could set a new and questionable precedent, according to NAD Director Andrea Levine.

You may also be interested in...



L’Oreal Win In UK Ad Forum May Be Best Promotion For Maybelline Mascara

The UK’s Advertising Standards Authority accepts that L’Oreal’s Maybelline Total Temptation Mascara really does award the lashes seen in advertising without pre- or post-production enhancements. A complainant challenged a commercial for the product, convinced that the mascara’s effects were deceptively exaggerated.

ASA Ruling Signals UK May Be Less Tolerant Of Lash Inserts In Mascara Ads

Use of lash inserts in mascara ads has been a subject of contention in the US, but a 2014 verdict from the National Advertising Review Board essentially green-lighted their continued use with proper disclaimers. The same leeway may not be available in the UK, based on an April 19 ruling from the Advertising Standards Authority.

Philosophy To Defend Time in a Bottle Claims With NARB Appeal

NAD recommends discontinuation of numerous claims, many on product packaging, for the Coty brand’s Time in a Bottle Age-Defying Serum, citing flaws in the advertiser’s six-month, blinded clinical study. Philosophy will appeal to the National Advertising Review Board, arguing that “left uncorrected, the NAD’s decision would … disincentivize manufacturers from conducting similar comprehensive studies.”

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel